ENTtoday
  • Home
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Multimedia
    • Video
    • Audio
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Mixing Vials of Allergy Drugs in the Office: Safety Standards and Testing

by Margot Fromer • November 1, 2007

  • Tweet
  • Email
Print-Friendly Version

WASHINGTON, DC—Compounding sterile medications for parenteral use, such as allergy drugs, in a private physician’s office is potentially subject to almost as much scrutiny and regulation as are visited upon commercial preparers of such medicines.

You Might Also Like

  • Proposed Vial Mixing Standard May Have Adverse Effects for Otolaryngologists
  • HIPAA Privacy and Security Standards for the Electronic Office
  • American Academy of Otolaryngic Allergy Focused on Advocacy, Patient Care
  • FDA Approves First Sublingual Allergy Immunotherapy Agents
Explore This Issue
November 2007

Otolaryngologists, with their many allergy patients, are among the specialists most affected by these rules, regulations, and standards. These standards have been established in order to reduce some of the 17 billion adverse medical events that occur each year in the United States. Of that number, 44,000 deaths result from medical error, of which mistakes in mixing and compounding allergy medicines are a part.

USP: The Gold Standard

Steven M. Houser, MD, Assistant Professor of Otolaryngology at Case Western Reserve University in Cleveland, told the miniseminar audience that the US Pharmacopeia (USP) is the gold standard of vial mixing. He said that although USP is not a government entity, it does have enforcement power, and it is the basis for procedure and safety in compounding sterile medications for parenteral use. USP has five major criteria in this area:

  • Preventing microbial contamination (maintaining sterility).
  • Removing excessive bacterial endotoxins from the medications.
  • Eliminating variability in the strength of correct ingredients.
  • Preventing unintended chemical and physical contamination.
  • Using only correct types and qualities of ingredients in sterile preparations.

To achieve these objectives, USP has developed a manual that covers in minute detail the steps to be taken and the correct procedure to be followed for compounded sterile preparations (CSPs). Chapter 797, Pharmaceutical Compounding—Sterile Preparations, pertains to private physician offices, and it is with this document that most of the miniseminar was concerned.

Chapter 797 went into effect on January 1, 2004, and covers a wide range of topics about compounding sterile preparations, labeling, and storage. The standards are enforced by the Food and Drug Administration and state boards of pharmacy. The Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) has adopted the USP guidelines, but JCAHO is interested mostly in hospital pharmacies, which, in many cases, check and test procedures in physicians’ offices.

Sandra Lin, MD

Sandra Lin, MD

CSPs are administered to patients via application, implantation, infusion, inhalation, injection, insertion, instillation, and irrigation. There are four categories of CSPs: low risk, medium risk, high risk, and immediate use. Physician office preparation falls into the medium risk category.

Figure. The most critical component in the preparation of CSPs is maintenance of sterility—in the compound itself and in the area where it is mixed.

click for large version
Figure. The most critical component in the preparation of CSPs is maintenance of sterility—in the compound itself and in the area where it is mixed.

CSPs are defined as biologics, diagnostics, drugs, nutrients, and radiopharmaceuticals, all of which are manufactured sterile products that must be prepared in a physician’s office according to the manufacturer’s instructions.

Pages: 1 2 3 | Single Page

Filed Under: Allergy, Practice Focus Issue: November 2007

You Might Also Like:

  • Proposed Vial Mixing Standard May Have Adverse Effects for Otolaryngologists
  • HIPAA Privacy and Security Standards for the Electronic Office
  • American Academy of Otolaryngic Allergy Focused on Advocacy, Patient Care
  • FDA Approves First Sublingual Allergy Immunotherapy Agents

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Is There a Crisis in the Otolaryngology Match?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Post-Tonsillectomy Taste Disorders Rare but Present
    • Study: Artificial Intelligence Can Help Predict Risk of Thyroid Cancer on Ultrasound
    • Nobel Awards for Otolaryngology Research
    • Visual Abstract Competition to Launch at 2020 Triological Society Sections Meeting
    • More Severe OSA Leads to Higher Blood Pressure in Patients with Resistant Hypertension
    • Link Between Hearing and Cognition Begins Earlier Than Once Thought

Polls

Will registry information and data science improve patient care?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2019 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.